VanEck Uranium and Nuclear ETF(NLR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

NLR VanEck Uranium and Nuclear ETF

Trading 12-22 10:45:39 EST

128.79

+1.77

+1.39%

High130.10	Low127.49	Vol150.43K
Open128.75	D1 Closing127.02	Amplitude2.05%
Mkt Cap3.67B	Tradable Cap3.67B	Total Shares28.49M
T/O19.39M	T/O Rate0.53%	Tradable Shares28.49M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"NLR","market":"US","secType":"STK","nameCN":"VanEck Uranium and Nuclear ETF","latestPrice":128.7901,"timestamp":1766418337169,"preClose":127.0239,"halted":0,"volume":150431,"delay":0,"floatShares":28491632,"shares":28491632,"eps":0,"marketStatus":"Trading","change":1.7662,"latestTime":"12-22 10:45:39 EST","open":128.75,"high":130.1,"low":127.49,"amount":19390146.727679998,"amplitude":0.020547,"askPrice":129.45,"askSize":1,"bidPrice":128.49,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1766437200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":127.0239,"sharesOutstanding":28741632,"nav":128.90079,"aum":3704819028.68,"dividendRate":0.004751,"bidAskSpread":0.00237,"preHourTrading":{"tag":"盘前","latestPrice":129.0025,"preClose":127.0239,"latestTime":"09:29 EST","volume":606,"amount":78104.26152,"timestamp":1766413798067},"postHourTrading":{"tag":"盘后","latestPrice":131.5,"preClose":130.19,"latestTime":"19:30 EST","volume":2354,"amount":303977.7542,"timestamp":1766190654944},"volumeRatio":1.369953,"impliedVol":0.3534,"impliedVolPercentile":0.684},"requestUrl":"/m/hq/s/NLR","defaultTab":"news","newsList":[{"id":"2588058732","title":"BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2588058732","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588058732?lang=en_us&edition=fundamental","pubTime":"2025-12-02 20:30","pubTimestamp":1764678600,"startTime":"0","endTime":"0","summary":"Three poster presentations at the San Antonio Breast Cancer Symposium (SABCS), now available and to be presented on December 10, 2025, highlight robust survival and clinical benefit data in Phase 2, p","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/02/3197795/0/en/BriaCell-to-Present-Phase-2-Survival-Phase-3-Clinical-Data-at-SABCS-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4211","BCTX","PFS","BK4606","DTH","NLR","CPI","BK4139","BK4195"],"gpt_icon":0},{"id":"2584462545","title":"Indaptus Therapeutics Chief Scientific Officer Dr. Michael Newman to Present at the Donor Selection & Cell Source Summit","url":"https://stock-news.laohu8.com/highlight/detail?id=2584462545","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584462545?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:00","pubTimestamp":1763384400,"startTime":"0","endTime":"0","summary":"NEW YORK, Nov.  17, 2025  (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/17/3189055/0/en/Indaptus-Therapeutics-Chief-Scientific-Officer-Dr-Michael-Newman-to-Present-at-the-Donor-Selection-Cell-Source-Summit.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SMMF","BK4606","BK4139","NLR","LENZ","BK4211","BK4007","BK4539"],"gpt_icon":0},{"id":"2565307046","title":"Indaptus Therapeutics Provides Clinical Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2565307046","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565307046?lang=en_us&edition=fundamental","pubTime":"2025-09-05 04:01","pubTimestamp":1757016060,"startTime":"0","endTime":"0","summary":"Decoy20 monotherapy induces Partial Response in patient with urothelial cancer and liver metastases Decoy20 combination with PD-1 inhibitor, tislelizumab, demonstrates safety profiles consistent with ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/04/3144954/0/en/Indaptus-Therapeutics-Provides-Clinical-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLR","BK4139","BK4007","BK4539","LENZ","BK4606"],"gpt_icon":0},{"id":"2564338313","title":"Indaptus Therapeutics to Present at the H.C. Wainwright 27ᵗʰ Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2564338313","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2564338313?lang=en_us&edition=fundamental","pubTime":"2025-09-03 04:05","pubTimestamp":1756843500,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  02, 2025  (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP) announced today that Jeffrey A. Meckler, Chief Executive Officer, will present a corporate overview at the H.C","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/09/02/3143149/0/en/Indaptus-Therapeutics-to-Present-at-the-H-C-Wainwright-27%E1%B5%97%CA%B0-Annual-Global-Investment-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NLR","LENZ","BK4539","BK4007","BK4606","BK4139"],"gpt_icon":0},{"id":"1111234473","title":"What Are the Highlights of This Year's Academician Selection Candidate List? \"Post-85s\" Make Their Debut as Stars Shine in Cutting-Edge Fields","url":"https://stock-news.laohu8.com/highlight/detail?id=1111234473","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111234473?lang=en_us&edition=fundamental","pubTime":"2025-08-21 22:24","pubTimestamp":1755786261,"startTime":"0","endTime":"0","summary":"On August 20, the Chinese Academy of Sciences (CAS) and Chinese Academy of Engineering (CAE) announced the valid candidate lists for 2025 academician selection, with 639 valid candidates for CAS...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4606","NLR"],"gpt_icon":0},{"id":"1128589509","title":"Yan Ning Recommends Fellow Alumni Biologist as Effective Candidate for Chinese Academy of Sciences Academician Election This Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1128589509","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128589509?lang=en_us&edition=fundamental","pubTime":"2025-08-21 14:31","pubTimestamp":1755757886,"startTime":"0","endTime":"0","summary":"The Chinese Academy of Sciences and Chinese Academy of Engineering announced on August 20 the list of effective candidates for the 2025 academician election. There are 639 effective candidates for...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4606","NLR"],"gpt_icon":0},{"id":"2554710326","title":"Nuclear Power Is Going Mainstream. These Stocks Stand to Benefit","url":"https://stock-news.laohu8.com/highlight/detail?id=2554710326","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2554710326?lang=en_us&edition=fundamental","pubTime":"2025-07-28 15:00","pubTimestamp":1753686000,"startTime":"0","endTime":"0","summary":"Nuclear power is quietly becoming a central pillar in the global shift toward low-carbon energy, as high-profile companies like Amazon.com, Meta Platforms, and Alphabet embrace it.That’s benefiting...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"9b624aa5c624d04c67827644384a28f5","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BD4GTV84.USD","BK4550","BK4187","BK4208","IE0031619046.USD","IE00B66KJ199.SGD","LU0205194284.USD","SG9999014005.SGD","IE00B19Z4B17.USD","LU0240877869.USD","LU0240878834.USD","NLR","IE00BMG7P819.SGD","IE00BMG7P694.USD","IE00B7SZL793.SGD","OKLO","PEG","BK4585","IE00BMG7P587.USD","SG9999014021.USD","BK4539","BK4567","BK4588","IE00BD4GTW91.USD","SG9999014013.SGD","BK4234","IE00BMG7P926.USD","BK4081","BK4606","IE00BD4GTT62.SGD","BK4591","LU0205193047.USD","BK4084","BWXT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vaneck.com/etf/equity/nlr/overview/","stockEarnings":[{"period":"1week","weight":0.0031},{"period":"1month","weight":0.0046},{"period":"3month","weight":-0.0522},{"period":"6month","weight":0.2162},{"period":"1year","weight":0.5746},{"period":"ytd","weight":0.6006}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes equity securities and depositary receipts issued by companies involved in uranium and nuclear energy. The fund is non-diversified.","yearOnYearQuotes":[{"month":1,"riseRate":0.611111,"avgChangeRate":0.01122},{"month":2,"riseRate":0.5,"avgChangeRate":-0.013583},{"month":3,"riseRate":0.611111,"avgChangeRate":-0.006283},{"month":4,"riseRate":0.611111,"avgChangeRate":0.023759},{"month":5,"riseRate":0.611111,"avgChangeRate":0.023688},{"month":6,"riseRate":0.388889,"avgChangeRate":-0.007919},{"month":7,"riseRate":0.611111,"avgChangeRate":-0.024426},{"month":8,"riseRate":0.555556,"avgChangeRate":-0.006992},{"month":9,"riseRate":0.578947,"avgChangeRate":0.005443},{"month":10,"riseRate":0.631579,"avgChangeRate":0.018099},{"month":11,"riseRate":0.578947,"avgChangeRate":-0.005854},{"month":12,"riseRate":0.473684,"avgChangeRate":-0.022286}],"exchange":"ARCA","name":"VanEck Uranium and Nuclear ETF","nameEN":"VanEck Uranium and Nuclear ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VanEck Uranium and Nuclear ETF(NLR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest VanEck Uranium and Nuclear ETF(NLR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"VanEck Uranium and Nuclear ETF,NLR,VanEck Uranium and Nuclear ETF股票,VanEck Uranium and Nuclear ETF股票老虎,VanEck Uranium and Nuclear ETF股票老虎国际,VanEck Uranium and Nuclear ETF行情,VanEck Uranium and Nuclear ETF股票行情,VanEck Uranium and Nuclear ETF股价,VanEck Uranium and Nuclear ETF股市,VanEck Uranium and Nuclear ETF股票价格,VanEck Uranium and Nuclear ETF股票交易,VanEck Uranium and Nuclear ETF股票购买,VanEck Uranium and Nuclear ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VanEck Uranium and Nuclear ETF(NLR),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest VanEck Uranium and Nuclear ETF(NLR) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction